Review
[Mitochondrial fusion protein Mfn2 and cardiovascular diseases]
[Article in
Chinese]
Affiliations
- PMID: 21417008
Item in Clipboard
Review
[Mitochondrial fusion protein Mfn2 and cardiovascular diseases]
[Article in
Chinese]
Sheng Li Ke Xue Jin Zhan.
2010 Feb.
Abstract
Mitofusin 2 (Mfn2) is a mitochondrial dynamin-related protein involved in the mitochondrial fusion reaction and is also connected to an altered mitochondrial energy supply. Mfn2 is a signaling molecule, plays an important role in cell proliferation, differentiation and apoptosis, which participates in the pathophysiology of several cardiovascular diseases, such as hypertension, restenosis after angioplasty, atherosclerosis, cardiac hypertrophy, and cardiac oxidative stress injury. Regulating the mitochondria-related metabolism, Mfn2 affects diabetes and insulin resistance pathogenesis. In addition, Mfn2 could be an important biomarker and therapeutic target molecule for cardiovascular diseases.
Similar articles
-
Mitofusin-2 protects against cold stress-induced cell injury in HEK293 cells.Biochem Biophys Res Commun. 2010 Jun 25;397(2):270-6. doi: 10.1016/j.bbrc.2010.05.099. Epub 2010 May 24. Biochem Biophys Res Commun. 2010. PMID: 20580691
-
Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity.J Cell Sci. 2004 Dec 15;117(Pt 26):6535-46. doi: 10.1242/jcs.01565. Epub 2004 Nov 30. J Cell Sci. 2004. PMID: 15572413
-
A form of mitofusin 2 (Mfn2) lacking the transmembrane domains and the COOH-terminal end stimulates metabolism in muscle and liver cells.Am J Physiol Endocrinol Metab. 2013 Nov 15;305(10):E1208-21. doi: 10.1152/ajpendo.00546.2012. Epub 2013 Aug 13. Am J Physiol Endocrinol Metab. 2013. PMID: 23941871
-
MFN2-related neuropathies: Clinical features, molecular pathogenesis and therapeutic perspectives.J Neurol Sci. 2015 Sep 15;356(1-2):7-18. doi: 10.1016/j.jns.2015.05.033. Epub 2015 May 29. J Neurol Sci. 2015. PMID: 26143526 Review.
-
Mitochondrial dynamics in mammalian health and disease.Physiol Rev. 2009 Jul;89(3):799-845. doi: 10.1152/physrev.00030.2008. Physiol Rev. 2009. PMID: 19584314 Review.
Cited by
-
Disruption of microRNA-214 during general anaesthesia prevents brain injury and maintains mitochondrial fusion by promoting Mfn2 interaction with Pkm2.J Cell Mol Med. 2020 Dec;24(23):13589-13599. doi: 10.1111/jcmm.15222. Epub 2020 Nov 4. J Cell Mol Med. 2020. Retraction in: J Cell Mol Med. 2024 Jan;28(2):e18095. doi: 10.1111/jcmm.18095. PMID: 33147380 Free PMC article. Retracted.
-
Mitofusin-2 acts as biomarker for predicting poor prognosis in hepatitis B virus related hepatocellular carcinoma.Infect Agent Cancer. 2018 Nov 26;13:36. doi: 10.1186/s13027-018-0212-7. eCollection 2018. Infect Agent Cancer. 2018. PMID: 30498519 Free PMC article.
-
The structure and function of mitofusin 2 and its role in cardiovascular disease through mediating mitochondria-associated endoplasmic reticulum membranes.Front Cardiovasc Med. 2025 May 30;12:1535401. doi: 10.3389/fcvm.2025.1535401. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40520935 Free PMC article. Review.
-
Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis.J Cell Mol Med. 2019 Jul;23(7):4611-4626. doi: 10.1111/jcmm.14341. Epub 2019 May 18. J Cell Mol Med. 2019. PMID: 31104361 Free PMC article.
-
Mitochondria-associated endoplasmic reticulum membranes and cardiac hypertrophy: Molecular mechanisms and therapeutic targets.Front Cardiovasc Med. 2022 Oct 20;9:1015722. doi: 10.3389/fcvm.2022.1015722. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36337896 Free PMC article. Review.